A unifed global genotyping framework of dengue virus serotype-1 for a stratifed coordinated surveillance strategy of dengue epidemics
Published in Microbiology
Dengue, caused by dengue virus (DENV) infection and mainly transmitted by Aedes mosquitoes, is now considered the most prevalent arboviral disease in human, and it circulates predominantly in tropical and subtropical regions, with more than half the world’s population at its risk. Dengue was listed in "Ten threats to global health in 2019" by the World Health Organization.
Urbanization, climate change, and globalization including rising global tourism are re-shaping the phylogeographic structure of virus populations, possibly contributing to a succession of severe viral pandemics as an unprecedented challenge to global public health. To investigate viral dispersion mechanisms in phylogeography and phylodynamics, various analytical methods and general genotyping methods have been developed for more accurate pathogen identification beyond viral species. Recently, the high-resolution genotyping scheme for surveillance manifested itself to be powerful in rapidly tracking the active lineages and transmission chains of SARS-CoV-2. Even though disease burden assessment and prediction using mosquito ecological data and dengue epidemic data have been investigated globally, there is still lack of a systematic scheme for understanding the DENV population structure, dynamics and mechanisms of cross-national, cross-regional, and even cross-continental transmission in a global profile.
Targeting DENV-1 spreading prominently in recent decades, by reconciling all qualified complete E gene sequences of 5003 DENV-1 strains, with the relative epidemiological information confirmed by literature research, from 78 epidemic countries/areas ranging from 1944 to 2018, the present study has established a unified global high-resolution genotyping framework of DENV-1 designating three hierarchical layers of clade, subgenotype and genotype with respective mean pairwise distances (MPDs)≦0.8%, 0.8-2%, and 2-6%.

Global genotyping framework of DENV-1 established based on its population structure, phylogeny, and epidemiology.
Figure 1 of the paper by Li et al.
On the one hand, the global epidemic patterns of DENV-1 showed strong geographic constraints representing stratified spatial-genetic epidemic pairs of Continent-Genotype, Region-Subgenotype and Nation-Clade. Thereby 12 epidemic regions have been identified including: GMS-China, Great Mekong Subregion-China; SEA, Southeast Asia; PHI, Philippines; TWP, Tropical Western Pacific; OCE, Oceania; WAFR, West African Region; RSR, Red Sea Region; SWIO, Southwest Indian Ocean; SASC, South Asia Subcontinent; CNA, Central North America; CAR, Caribbean; and SA, South America, which prospectively facilitates the region-based coordination. As for the pair of the Region-Subgenotype, 92.3% and 71.8% of the 39 designated subgenotypes, with ≥50% and ≥80% isolates respectively, mainly circulated in a single region.
On the other hand, the present study also reminds us to be concerned about the cross-regional and even cross-continental diffusion of DENV-1, which potentially arouse large epidemics, in reference to the stratified spatial-genetic epidemic pairs. For example, several subgenotypes including 5K, 5B, 4F, 5C, 5M and 5N were found spreading across several regions. The cross-regional transmissions were mostly observed in adjacent regions, especially in the regions of Asian or American Continents, but only a few cross-continental transmissions occurred. Collectively, the transmissions of subgenotypes cross countries/regions, on the rise in recent decades, can explain its continuous global expansion to some extent. Therefore, international collaborations based on the framework in promptly pinpointing and periodically updating the hotspots of emerging, transmission, drifting, and replacement of DENV-1 will give rise to cost-effective surveillance strategy for regional and global control of dengue.
In addition, through in-depth explorations of the global transmission pattern of DENV-1 using this framework, we observed that the traditional endemic countries such as Thailand, Vietnam, Indonesia, the Philippines, India, and Brazil apparently displayed as the persisting dominant source centers, while the emerging epidemic countries such as China, Australia, and the USA, where dengue outbreaks were frequently triggered by importation, showed a growing trend of DENV-1 diffusion. Meanwhile, the singletons in subgenotypes (12/41) and clades (63/208) recognized in our study suggest that they may be partially caused by widely deficient surveillance. The probably hidden epidemics were found especially in Africa and India. Then, our framework can be utilized in an accurate daily coordinated surveillance based on the population compositions of its clades and subgenotypes, which is prospectively valuable for hampering the ongoing transition process of epidemic to endemics and addressing the issue of inadequate monitoring.
The genotyping framework and its utilization in quantitatively assessing DENV-1 epidemics has laid a foundation and re-unveiled the urgency for establishing a stratified coordinated surveillance platform for blocking global spreading of dengue. This framework is moreover expected to bridge classical DENV-1 genotyping with genomic epidemiology and even pathogen-mosquito-disease-associated risk modelling. The authors will promote the public availability to the framework and keep periodic updating of it as well.

Graphical abstract of the paper by Li et al.
https://idpjournal.biomedcentral.com/articles/10.1186/s40249-022-01024-5
Follow the Topic
Related Collections
With Collections, you can get published faster and increase your visibility.
Sustaining research capacity: competency building and implementation in low and middle-income countries
Infectious diseases of poverty continue to impose a disproportionate burden on low and middle-income countries (LMICs). Strengthening research capacity in these settings is critical for generating locally relevant evidence and improving health outcomes. In response to this need, Infectious Diseases of Poverty is pleased to announce a special issue entitled “Sustaining Research Capacity: Competency Building and Implementation in Low- and Middle-Income Countries.”
This special issue aims to provide a platform for rigorous analysis of research capacity strengthening initiatives, moving beyond immediate outputs to examine long-term outcomes and sustainability. We invite submissions that explore the effectiveness of training programs, including postgraduate schemes, fellowships, and institutional partnerships, with a focus on implementation research and clinical research leadership in low and middle-income countries. We encourage manuscript submissions that address, but are not limited to, the following themes:
• Career Trajectories and Retention: Evidence of how training programs influence career progression, retention within LMICs, and the transition into leadership roles.
• Scientific Outputs and Bibliometrics: Retrospective and prospective evaluations of research productivity, including publication volume, authorship positions, journal quality, and citation networks.
• Collaboration and Networking: Assessments of how training influences national, South-South, and North-South collaboration patterns.
• Institutional Capacity and Curriculum Development: Evaluations of how training programmes strengthen institutional research ecosystems, including curriculum integration (e.g., the inclusion of implementation research modules), faculty development, and the establishment of sustainable research agendas.
• Challenges and Barriers: Qualitative and quantitative analyses of the obstacles researchers face post-training, such as limited funding opportunities, publication inequities, and the scarcity of high-level positions.
We welcome a variety of article types, including original research articles, scoping reviews and policy briefings. Manuscripts should offer methodological rigor and provide actionable insights for funders, policymakers and academic institutions to optimize future investments in research capacity strengthening. This Collection supports and amplifies research related to SDG 10, Reduced Inequalities.
All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Ongoing
Urbanization and Infectious Diseases
A thematic series in Infectious Diseases of Poverty.
We are experiencing the process of global large-scale urbanization and nearly 70% of the world’s population will live in urban areas by 2050 according to the World Urbanization Prospects issued by the United Nations. Urbanization has the pros and cons like a double-edged sword. Improved health services, better infrastructure and more employment opportunities benefit people a lot, but the overcrowding, environmental pollution, dietary changes and traffic jam may cause health problems.
Non-communicable diseases have attracted researcher’ concern due to its increasing importance during the process of urbanization (e.g., cardiovascular disease, diabetes, mental health, hypertension, obesity), but the communicable diseases seem to be neglected. The ongoing global pandemic caused by COVID-19 warns us again about the potential threats from infectious diseases, the wide connectivity, heightened mobilities and potential zoonotic risks from rapid urbanization became immediately apparent for human health. For low-income countries, infectious diseases still have a profound impact since the leading morbidity and mortality are still infectious diseases and many of those low-income countries will have a major growth among urban population in the future. Urbanization can result in an amount of changes such as the environment, climate, biodiversity, wildlife habitat, social and spatial aspect, human behavior and population movement and land-use, which will re-shape the (re)emergence and trajectory of infectious diseases, both human diseases and zoonotic diseases contributing to the occasionally cross species spillovers from wildlife populations to humans.
As a complex dynamic process, urbanization is associated with human, domestic poultry, wild birds, environment and even expanded interfaces of contacts among them, which may all result in increased vulnerability to infectious disease. Besides, due to different urbanization process, social class and educational level, the influence of urbanization on infectious diseases will be very heterogeneous and the local diseases and health challenges can greatly differ. Hence, a multi-disciplinary and multi-sectoral approach including epidemiology, geography, sociology, ecology, zoology, veterinary science, statistics and others is needed to better illuminate the relationship between urbanization and infectious diseases.
In order to better understand the impact of urbanization on infectious diseases and provide rational policy suggestions on improving human health, the journal of Infectious Diseases of Poverty is launching a new Thematic Series entitled Urbanization and infectious diseases. This series will focus on better evidence of impacts of the urbanization process on various infectious diseases, included but not limited to vector-borne infectious diseases, water-borne diseases, food-borne diseases, natural focus disease or endemic disease, respiratory diseases, zoonotic diseases and emerging infectious diseases.
Publishing Model: Open Access
Deadline: Ongoing
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in